Resmed Inc (NYSE:RMD)
| 255.42 Delayed Data As of Oct 15 |  -0.07 / -0.03%Today’s Change | 177.70 Today|||52-Week Range 301.34 | +20.16% Year-to-Date |
Latest RMD News | Press Releases
| Schwab Charitable Fund Buys Schwab 1000 Index ETF, SPDR Bloomberg Barclays Short Term High ... Oct 14 / GuruFocus News - Paid Partner Content | 3 Top Healthcare Stocks to Buy Right Now Oct 13 / MotleyFool.com - Paid Partner Content |
| Resmed Inc (RMD) CFO Brett Sandercock Sold $1.3 million of Shares Oct 13 / GuruFocus News - Paid Partner Content | Here's Why You Should Retain ResMed (RMD) Stock for Now Oct 07 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 255.49 |
| Today’s open | 255.77 |
| Day’s range | 255.55 - 257.94 |
| Volume | 570,937 |
| Average volume (3 months) | 543,186 |
| Market cap | $37.2B |
Data as of 3:59pm ET, 10/15/2021
Growth & Valuation
| Earnings growth (last year) | -24.19% |
| Earnings growth (this year) | +17.65% |
| Earnings growth (next 5 years) | +14.70% |
| Revenue growth (last year) | +8.11% |
| P/E ratio | 78.9 |
| Price/Sales | 11.29 |
| Price/Book | 12.90 |
Competitors
Data as of 4:00pm ET, 10/15/2021
Financials
| Next reporting date | October 28, 2021 |
| EPS forecast (this quarter) | $1.37 |
| Annual revenue (last year) | $3.2B |
| Annual profit (last year) | $474.5M |
| Net profit margin | 14.84% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
